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MAPKs engage substrates, MAP2Ks, and phospha-
tases via a docking groove in the C-terminal domain
of the kinase. Prior crystallographic studies on the un-
phosphorylated MAPKs p38a and ERK2 defined the
docking groove and revealed long-range conforma-
tional changes affecting the activation loop and active
site of the kinase induced by peptide. Solution NMR
data presented here for unphosphorylated p38a with
a MEK3b-derived peptide (p38a/pepMEK3b) validate
these findings. Crystallograhic data from doubly
phosphorylatedactivep38a (p38a/T*GY*/pepMEK3b)
reveal a structure similar to unphosphorylated p38a/
MEK3b, and distinct from phosphorylated p38g
(p38g/T*GY*) and ERK2 (ERK2/T*EY*). The structure
supports the idea that MAP kinases adopt three
distinctconformations: unphosphorylated,phosphor-
ylated, and a docking peptide-induced form.
INTRODUCTION
MAPK cascades are central transducers of information from the
plasma membrane to intracellular targets and regulate diverse
cellular processes including proliferation, differentiation, trans-
formation, cell death, and senescence (Deng et al., 2004; John-
son and Lapadat, 2002). One of the best-studied cascades is
the p38aMAP kinase and its activators MEK6 and MEK3, which
are involved in stress responses (Zarubin and Han, 2005). p38a
MAP kinase has received attention as a drug target and is under
study for the treatment of rheumatoid arthritis, pain, dementia,
and stroke (for review, see Borders et al., 2008; Loeser et al.,
2008; Schindler et al., 2007). MAP kinases are typical small
protein kinases, which possess N- and C-terminal domains,
and the C-terminal domain houses the activation loop with its
two phosphorylation sites, a Tyr and a Thr. The regulation of
MAP kinase activity is complex. The two phosphorylation sites
are phosphorylated by MAP2Ks (Mansour et al., 1994) and are
the target of dual specificity (Dickinson and Keyse, 2006), Tyr,
and Ser/Thr phosphatases (Saxena and Mustelin, 2000). Phos-
phorylation induces a different, presumably active conformer
(Canagarajah et al., 1997; Bellon et al., 1999). MAP kinases utilize
a docking strategy to bindMAP2Ks andphosphatases, aswell as
substrates in which linear sequence motifs in MAPK interactingStructure 18, 1571–15partners bind the MAPK at loci outside the active site of the
kinase. The most ubiquitous docking motifs are the ‘‘D-motifs’’
(also referred to as ‘‘DEJL’’; Lee et al., 2004; Jacobs et al.,
1999), originally defined in substrates (Kallunki et al., 1996;Enslen
et al., 2000), then in MAP2Ks (Bardwell and Thorner, 1996; Xia
et al., 1998; Xu et al., 1999) and phosphatases (Zuniga et al.,
1999). D-motifs are selective and have been shown to confer
pathway specificity despite relatively weak (micromolar) binding
constants (Bardwell et al., 2009; Smith et al., 2000; Bardwell
and Shah, 2006). The loci of interaction between D-motifs and
MAP kinases have been defined bymutagenic analysis (Bardwell
et al., 2001; Barsyte-Lovejoy et al., 2002; Gum and Young, 1999;
Tanoue et al., 2000, 2001; Zuniga et al., 1999) and crystallo-
graphic studies (Chang et al., 2002; Heo et al., 2004; Liu et al.,
2006; Remenyi et al., 2005; Zhou et al., 2006b). The D-motif
binding site is comprised of two subsites, an acidic patch (named
CD; Tanoue et al., 2000), and a ‘‘hydrophobic docking groove’’
(Chang et al., 2002). These two subsites correspond well to the
bipartite D-motif, originally defined to encompass a cluster of
positive charges followed by a hydrophobic motif (Sharrocks
et al., 2000). The complete D-motif interaction defined by muta-
genic analysis has been observed in ERK2 (Zhou et al., 2006b)
and the yeastMAPKFus3 (Remenyi et al., 2005), whereas studies
in p38a (Chang et al., 2002), and JNK1 (Liu et al., 2006) have
revealed interactions primarily in the hydrophobic docking
groove. The docking groove is located near helices D and E and
the b7-b8 reverse turn (standard kinase nomenclature).
Crystallographic studies of docking interactions in p38a and
ERK2 have suggested D-motifs induce a third conformer of the
MAPK that is close to the active form of MAPKs, but causes
the activation loops to be disordered or more solvent accessible
(Zhou et al., 2006b). We postulated that this conformational
change facilitates the binding of the activation loop of the
MAPK into the active site of another enzyme, such as the
MAP2K or phosphatase. These data raise the question of
whether similar conformers occur in solution. Here, we demon-
strate that docking peptides induce conformational changes in
solution in unphosphorylated p38a. Unphosphorylated p38a
gives a 15N-1H TROSY spectrum, over 60% of which has been
assigned (Vogtherr et al., 2006). A peptide derived from the
MAP2K MEK3b (pepMEK3b) induces chemical shift changes
that correlate well with the crystallographic analysis of unphos-
phorylated p38a, confirming the peptide binding site and the
presence of local and long-range conformational changes. This
is the largest protein for which long-range allosteric effects
have been observed by NMR and compared with crystallo-
graphic measurements of the exact same process.78, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1571
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Figure 1. The Structure and Electron
Density of p38a/T*GY*/pepMEK3b
(A) The kinase domain is pink, the activation loop in
magenta, with disordered residues indicated as
dots, and D-motif peptide in cyan (drawn in Pymol)
(DeLano, 2002).
(B) PepMEK3b electron density in p38a/T*GY*/
pepMEK3b (green), backbone of p38a/T*GY*/
pepMEK3b (pink and cyan) overlayed on the
backbone of p38a (blue), with all corresponding
cas superimposed. Of the peptide in the crystalli-
zation, SKGKSKRKKDLRISCASK, the sequence
KKDLRISCASK is visible, three more residues
than found in p38a/pepMEK3b.
(C) Electron density for the phosphorylation sites of
p38a (PDB file 1P38).
(D) Electron density in the same area p38a/
pepMEK3b (PDB file 1LEZ, atoms in magenta).
(E) Electron density in p38a/T*GY*/pepMEK3b (this
study, atoms in magenta). Differences between
p38a/pepMEK3b and p38a/T*GY*/pepMEK3b are
most significant on V183 and T185.
(F) Same region in doubly phosphorylated ERK2
(PDB file 2ERK, atoms in yellow), showing pY185.
The folding is different, but W190 of ERK2
occupies a similar position and conformation to
W187 in p38a. R189 of ERK2 corresponds to
R186 p38a, but is differently positioned. The
pT183 of ERK2 is not shown. All maps were con-
toured at 0.8 s.
See also Figure S1.
Structure
Third Conformation of p38aFurther, previous observations leave open the question of
whether docking peptides induce conformational changes in
the phosphorylated active form of MAPKs. Here, we present
the crystal structure of p38a/T*GY* (* indicating the activating
phosphorylation sites Thr180 and Tyr182) complexed with
a docking peptide from MEK3b (p38a/T*GY*/pepMEK3b).
pepMEK3b is a particularly tight binder for p38a and is an inhib-
itor of p38a/T*GY*(Bardwell et al., 2009). The observed structure
of the kinase is surprisingly similar to that of unphosphorylated
p38a/pepMEK3b and distinct from the known active conformers
of two related MAP kinases, p38g (Bellon et al., 1999) and ERK2
(Canagarajah et al., 1997). This is a third conformer of MAP
kinases, distinct from the ligand free unphosphorylated or phos-
phorylated forms, but available from either form on D-motif
peptide binding. The nature of the linkage between the docking
groove and the activation loop is discussed.
RESULTS AND DISCUSSION
Overall Structure of p38a/T*GY*/pepMEK3b
To crystallize p38a/T*GY*, p38a was coexpressed with its
activating enzyme MEK6, utilizing an active mutant (MEK6/
DD) (see Experimental Procedures). Electrospray mass spec-
trometry (see Figure S1 available online) revealed masses 240
and 320 higher than expected from sequence, consistent with1572 Structure 18, 1571–1578, December 8, 2010 ª2010 Elsevier Ltd All rights reservedthree and four phosphorylation events.
Mass spectrometry of a tryptic digestion
of MEK6/T*GY* showed Ser28 as a major
extra nonspecific phosphorylation site;elimination of Ser28 (mutation to Ala) reduced the heterogeneity
of phosphorylation and caused the doubly phosphorylated
form to be the dominant species (Figure S1B). This mutant,
phosphorylated in the activation loop, p38a/S28A/T*GY* is the
topic of this paper (and will be referred to simply as p38a/
T*GY*). The kinase was active toward myelin basic protein
(MBP) (data not shown). Crystallization trials of p38a/T*GY*
alone, with ATP, and with several docking peptides were con-
ducted. Included in the crystallization screen were D-motif
peptides derived from the substrate MEF2A, the phosphatases
MKP5 (MAP kinase phosphatase-5) and HePTP (hematopoietic
tyrosine phosphatase), and activator MEK3b (MAP/ERK kinase
3b). A complex with a MEK3b-derived peptide (pepMeK3b,
SKGKSKRKKDLRISCASK), crystallized. This peptide contains
the consensus motif R/K-X4-ØA-X-ØB and a cysteine residue
near its C terminus (Sharrocks et al., 2000). p38a/T*GY*/pep-
MEK3b crystallized in the same space group and lattice as
unphosphorylated p38a/pepMEK3b (Chang et al., 2002). The
initial R-/Rfree factors were 0.289/0.301 and refined to R and
R-free factors of 0.18 and 0.23, respectively.
The structure, diagrammed in Figure 1A, superimposes closely
with that of p38a/pepMEK3b (PDB file 1LEZ) with an overall rmsd
of 0.3 A˚, compared with 0.58 A˚ overall rmsd with p38a (PDB file
1P38), and 2.4 A˚ overall rmsd with p38g/T*GY* (PDB file 1CM8;
p38g shares 60% sequence identity with p38a). The peptide
Figure 2. Conformational Changes Linking the
Docking Groove and the Activation Loop
(A) The backbone trace for p38a is blue, p38a/T*GY*/pep-
MEK3b pink. The interaction of helix D with helix F, and the
interactions of the FG linker (residues 221–224), with L14
(between the MAP kinase insert and helix H, residues 270–
279) are shown. Part of the activation loop (residues180–
188) is shown, as are the side chains of L113, L117, Q120,
and L216. L113 and Q120, which move the most, are shown
in darker blue (p38a) and red (p38a/T*GY*/pepMEK3b). New
waters present in p38a /T*GY*/pepMEK3b but not p38a are
shown as red dotted spheres; similar waters present in
p38a/pepMEK3b are blue.
(B) Schematic of conformers of p38a. N- and C-terminal
domains shown in small and large blue eggs, helix D is purple,
activation loop is red, peptide is orange, water molecules
entering the C-terminal domain in p38a/pepMEK3b and
p38a /T*GY*/pepMEK3b are red. The difference in the orienta-
tion of the N- domain of the model for p38a/T*GY* is based on
the structure of active p38g.
See also Figures S2 and S3.
Structure
Third Conformation of p38a(Figure 1B) occupies a similar position to that in p38a/pepMEK3b
(1LEZ), utilizing the same pockets for the ØA-X-ØBmotif, forming
the same disulfide bridge between Cys (ØB+2) and Cys119, and
generally the interactions are similar to those described previ-
ously (Chang et al., 2002). The interacting proteins of p38a
MAP kinase MEK3b, MKP5 (dual specificity phosphatase 10,
DUSP10), and DUSP8 possess the Cys at position (ØB+2)
(Dickinson and Keyse, 2006). This disulfide is not required for
the interaction as measured in pull-down assays, but improves
the electron density (Chang et al., 2002) and is also not required
to observe changes in the TROSY spectrum relative to uncom-
plexed p38a (see Experimental Procedures). Three more
residues are visible in p38a/T*GY*/pepMEK3b than in unphos-
phorylated p38a/pepMEK3b (at positions ØB+3, ØB+4, and
ØB+5). At the N terminus, the lysine and arginine residues at the
known from mutagenesis to be involved in p38a interactions
(Barsyte-Lovejoy et al., 2002) are not visible in the electron
density of the complex, as is the case in p38a/pepMEK3b. A
significant conformational change occurs in the hydrophobic
docking groove in p38a/T*GY*/pepMEK3b, again similar to that
observed in p38a/MEK3b (Figure 1B). Gln120 in the linker
between D and F moves 6.5 A˚, a change induced by peptide,
where Gln120 rotates to bind the peptide backbone. Associated
with this motion is a large change in the orientation of Helix D,
involving residuesLeu113 toCys119.Theconformational change
also affects the entirety of the linker between helix D and helix E
(Gln120 to Thr123). Slight conformational changes are observed
in the CD domain (on Glu81, Arg136, and Asp316, even though
the peptide is not seen in this region (Figure 1B).Structure 18, 1571–1578, DecembeConformational Changes in the Activation
Loop and C-Terminal Domain
The peptide pepMEK3b induces disorder in the
activation loopof p38a/T*GY* (ribbon traceof back-
bone shown in Figure 1A). The activation loop of un-
phosphorylated p38a is fairlywell ordered as canbe
seen from the electron density (Figure 1C) (PDB file
1P38). Peptide binding to inactive p38a (p38a/
pepMEK3b,1LEZ) induces disorder (Figure 1D),including the phosphorylation sites Thr180 and Tyr182. In
p38a/T*GY*/pepMEK3b (Figure 1E) the disorder extends even
further, to Ala184 (Figure 1E), and Thr185 occupies a different
position (Figure 1E). This structure contrasts models for p38a/
T*GY* derived from the available structures of p38g/T*GY*
(1CM8) and ERK2/T*EY* (2ERK) (Figure 1F). These comparisons
suggest that theD-motif dockingpeptidehas induced long-range
conformational changes in p38a/T*GY*/pepMEK3b.
What happens in between the docking groove and the activa-
tion loop is interesting. Peptide binding causes helix D, to which
it binds directly, to move. As can be seen in Figure 2A, Val117,
which is on the opposite side of helix D from the docking groove,
becomes detached from the underlying structure. Val117 forms
contacts with Leu216 (in helix F) in p38a but loses the interaction
in p38a/T*GY*/pepMEK3b (over 2 A˚ change in side-chain
distance). Several water molecules have flooded into the
structure. The same new water molecules appear in p38a/
pepMEK3b. Apparently, the strain introduced by forming inter-
actions with the D-motif peptide is relieved by breaking relatively
weak van der Waals interactions on the opposite side of helix D
from the docking groove. This leads to a significant disruption of
the packing of the C-terminal domain. How this change in the
core of the C-terminal domain is linked to disorder transitions
in the activation loop is unclear, however. A cartoon representa-
tion of the conformational changes occurring in p38a is shown in
Figure 2B: peptide binding to either the inactive or active form of
the protein induces the same structure in which helix D rotates,
waters come into the C-terminal domain, and disorder is induced
in the activation loop.r 8, 2010 ª2010 Elsevier Ltd All rights reserved 1573
Figure 3. NMR-Based Evidence for Peptide-Induced Conforma-
tional Changes in p38a
15N-1H TROSY spectra of p38a with (red) and without (black) the 5 mM
pepMEK3b docking peptide recorded at 25C at 800 MHz. Unambiguously
assigned cross-peaks are labeled with the residue assignment.
Structure
Third Conformation of p38aA few other changes occurred in the structure, the largest in
the phosphate binding ribbon, around residue 32 (visualized in
the ca-shift plots) (Figures S2A and S3). Similar shifts are
observed in both p38a/pepMEK3b (Figure S2A) and in p38a/
T*GY*/pepMEK3b (Figure S3). The phosphate binding ribbon is
known to move easily (Wang et al., 1998).
Solution NMR Studies of p38a/pepMEK3b
Compared with many other kinases and proteins of this size,
p38a has reasonably good characteristics for solution NMR
studies. By combining a variety of isotopic labeling and spectro-
scopic strategies, Vogtherr et al. (2006) were able to assign the
majority of backbone chemical shifts for unphosphorylated
p38a, including 216 out of 360 backbone amide 15N/1H reso-
nances (Vogtherr et al., 2006). We used the chemical shift
assignments to unambiguously assign 133 backbone amides
by comparison of these shifts with those of 2D 15N/1H TROSY
spectra we acquired independently (Figure 3). We were not
able to transfer the assignments of 83 amides due to chemical
shift changes caused by minor changes in solution conditions
and/or peak overlap within these 2D spectra. Nevertheless, the
assignments we do have provide amide probes well distributed
throughout both domains of p38a (Figure 4).
To study D-motif peptide-induced conformational changes,
we recorded 2D 15N/1H TROSY spectra of unphosphorylated
p38a both alone and in the presence of pepMEK3b. The TROSY
chemical shift changes were identical with and without reducing
agent; the analysis presented here is for the reducing-agent free
complex in which a disulfide forms between Cys119 and Cys15
of the peptide. A minimum chemical shift approach was used to
establish changes between the two forms (Farmer et al., 1996).
This analysis is based on the conservative assumption that the
peak corresponding to a particular backbone amide in the
peptide-bound form is associated with the nearest apo- form
peak, erring on the side of underestimating changes in chemical
shift (Dd) for peaks with large changes.1574 Structure 18, 1571–1578, December 8, 2010 ª2010 Elsevier LtdUsing this approach, we found docking-induced chemical
shift changes at many of the amide probes present in 15N/1H
TROSY spectra. Of the unambiguously assigned sites, 16 ex-
hibited changes over 0.1 ppm, while 6 changed 0.05 ppm <
Dd < 0.1 ppm (Figures 4A and 4B and Table 1; Figure S2B).
Many of these perturbed sites were clustered along the D-motif
docking groove, including A111 that affects complex formation
when mutated (Chang et al., 2002), and Gln120 that exhibited
the largest docking-induced coordinate change. Many chemical
shift changes occur in residues near the CD acidic patch
(Asp315, Asp316, and Glu317 in murine p38a), previously
implicated by mutagenesis to be involved in p38a interactions
(Tanoue et al., 2000) (Figure 4B). Changes are observed on
nearby residues, including Asn82, Asp125, Phe129, Tyr140,
Leu303, and Tyr311. These changes in the TROSY spectrum
suggests that pepMEK3b does bind the CD acidic patch,
although these interactions were not observed crystallographi-
cally (Barsyte-Lovejoy et al., 2002; Chang et al., 2002).
Chemical shifts changes occur in the C-terminal domain (Fig-
ure 4C). Medium-range effects are seen on Gly110, Leu130,
Ser154, Asn159, Leu164, Ile166, and Arg220. These effects
appear to emanate isotropically from the docking site.
In addition, several residues quite remote (>30 A˚) from the
docking groove exhibited large shifts, including Phe270 (Fig-
ure 4C) and Ile297 (Figure 4A) in the C-terminal domain and
Val102 (Figure 4A) in the N-terminal domain. These latter
changes indicate the presence of long-range conformational
changes induced by peptide binding. Unfortunately very few
peaks were assigned near the activation loop, so it was not
possible to get support for the crystallographic observations in
this part of the structure from the TROSY data.
Nearly all of the residues that show shifts are buried, with the
exception of Gln120, which binds the peptide. Apparently,
buried residues have a greater susceptibility to undergo changes
in the electronic environment sufficient to alter the 15N/1H
TROSY spectra. Further, several residues that show changes
crystallographically, do not show large chemical shifts on
peptide binding. Some of the most notable are Lys118 and
Cys119, which are in between two residues with large chemical
shifts, Val117 and Gln120 (Figure 4B). Apparently these residues
move but do not experience a change in electronic environment.
Conclusions
The crystallographic data presented here reveals that D-motif
peptides induce conformational changes in the active form of
p38a (p38a/T*GY*/pepMEK3b). The resulting structure is very
close to that observed for peptide-bound unphosphorylated
p38a (p38a/pepMEK3b), and quite distinct from peptide-free
conformers of active MAPK homologs ERK2 and p38g. Appar-
ently, there are three important stable conformers of MAP
kinases. The function of the peptide-bound conformer in the
active form of the enzyme is not clear. It may serve a function
when phosphatases are bound, inducing a looser activation
loop structure that can bind more readily in the active site of
the phosphatase enzyme. As noted above, the peptide used in
this study was derived from a MAP2K, but this peptide is an
inhibitor of p38a/T*GY* and one of the tightest binding D-motif
peptides (Bardwell et al., 2009). The structure of an uncom-
plexed enzyme p38a/T*GY* is not available for comparison.All rights reserved
Figure 4. Superposition of p38a and p38a /pepMEK3b
Residues with unambiguously assigned 15N-1H TROSY cross-
peaks but do not show a shift on peptide binding are mapped
onto the structure of p38a as blue spheres, those with shifts
0.05 ppm < Dd < 0.1 ppm are shown in yellow, while those
with Dd > 0.1 ppm are red.
(A) Whole molecule.
(B) Same selection and view as in Figure 1B except that the
structure of a phosphatase-derived peptide bound to ERK2
(PDB file 2GPH), which forms interactions in the CD acidic
patch, is overlaid in gray.
(C) Same selection and view as Figure 1C.
Structure
Third Conformation of p38aHowever, in ERK2, the peptide-induced structure (bound to
unphosphorylated ERK2), was more similar to the ERK2/T*EY*
than to unphosphorylated ERK2 (Zhou et al., 2006b), thus
explaining how substrates and phosphatases use the same
docking groove and generate similar conformational changes.
When substrates bind at the active site, apparently other interac-
tions between the substrate and MAP kinase must help to
promote the active configuration. The conformational linkage
between the docking groove and the activation loop may be
important somehow to dissociation events, known to be
required during phosphorylation of MAP kinases (Huang and
Ferrell, 1996). This possibility will be addressed in future studies.
Comparison of p38a/T*GY*/pepMEK3b with unphosphory-
lated p38a shows displacements along helix D and disorder in
the activation loop. What is the conformational link between
these? The obvious possibility revealed by the crystal structure
is a loosening of interactions between helix D and the remainder
of theC-terminal domain. To our knowledge, this is the first report
of allostery by breaking van der Waals interactions and introduc-
tion of several extra water molecules into the body of the protein.
How thedisruptionof theC-terminal domain is linked to activation
loop disorder is not obvious. It is interesting in this regard that
there are three reports of interactions between the activation
loop and distal sites in the protein that induce autophosphoryla-
tion of p38 isoforms. The activator Tab1 binds in the docking
groove, inducing autophosphorylation (Zhou et al., 2006a).
Further, phosphorylation of p38a on Tyr323 in L16 by ZAP-70
(Salvadoret al., 2005) promotesautophosphorylation, asdoother
mutants in L16 (Avitzour et al., 2007). The latter phenomenon has
been studied by X-ray crystallography (Diskin et al., 2007) and,
very interestingly, the induced conformational changes involve
disorder along the D-helix, as well as the activation loop. ThisStructure 18, 1571–1578, Decembestudy highlights the importance of helix D in the
conformational equilibrium in this particular MAP
kinase. The observed conformation in autophos-
phorylating mutants, together with the lack of an
obvious chain of linked conformational changes in
our crystallographic studies support the idea
that the protein behaves as a system that is thermo-
dynamically linked. This idea is implied in the
Hopfield’s discussion of allostery in hemoglobin
(Hopfield, 1973) and contrasts with notions popular
in the current literature arguing that allostery occurs
along particular pathways (Masterson et al., 2008)
or networks (Suel et al., 2003).Comparisons of solution NMR spectra recorded on p38a and
p38a/pepMEK3b complement and support the crystallographic
findings. The NMRdata both validated the location of the D-motif
docking groove and showed that long-range conformational
changes are taking place, as supported by chemical shift
changes in amides over 20 A˚ away from the peptide binding
site. In addition, these data provided evidence that the basic
region of the D-motif (R/K-X4-ØA-X-ØB) is binding to unphos-
phorylated p38a in solution. This idea is supported from
mutagenic analysis but not by crystallography in p38a (Bar-
syte-Lovejoy et al., 2002). These interactions are observed in
ERK2 (Zhou et al., 2006b) and in the yeast MAPK Fus3 (Remenyi
et al., 2005).
The NMR measurements also offer a different perspective on
the mechanical nature of conformational change. The chemical
shift changes emanate from the docking groove isotropically.
This property has been observed previously, e.g., upon addition
of Ca(II) to calcium-binding domains (Breukels and Vuister,
2010). This observation is also consistent with the ‘‘distributed’’
model for dissipation of strain in proteins (Hopfield, 1973). In
p38a, strain leads to breaking of van der Waals interactions
between helix D and helix F, which are apparently weaker bonds
than the hydrogen bonds and van der Waals contacts afforded
by peptide binding (the susceptibility to fracture may not be
isotropic, however.) The peptide-induced conformational
changes observed in p38a are distinct from those occurring in
the other MAP kinases such as ERK2 (Zhou et al., 2006b). The
possible significance of unique conformational changes to
pathway specificity has been noted previously (Zhou et al.,
2006b).
We found it remarkable that the structure of p38a/T*GY*/
pepMEK3b matched so closely with that of p38a/pepMEK3b.r 8, 2010 ª2010 Elsevier Ltd All rights reserved 1575
Table 1. 15N/1H TROSY Shifts p38a-> p38a/MEK3b
Residues showing a shift greater than 0.1 ppm
Residue Where Inference or comment
N82 V-linker CD subsite binding
V102 b5 Long range effect
G110 Crossover connection Medium range effect
A111 Helix D Local effect
V117 Helix D facing Helix F Local effect
Q120 Linker Helices D-E Direct effect
E125 Helix E Docking groove
F129 Helix E near CD acidic patch CD subsite binding
L130 Helix E Docking groove
Y140 Helix E Medium range effect
N159 b7 Docking groove
L164 b8, packs on helix E Medium range effect
I166 b8, packs on helix E Long range effect
R220 Linker Helices F-G linker Medium range effect
F270 L14 linker Medium range effect
I297 Linker Helices H-I linker Medium range effect
Residues showing shifts between 0.05 ppm and 0.1 ppm
S154 Catalytic Loop Long range effect
V158 b7 Docking groove
L303 Near CD acidic patch CD subsite binding
Q310 Near CD acidic patch CD subsite binding
Y311 Near CD acidic patch CD subsite binding
V319 Near CD acidic patch CD subsite binding
Structure
Third Conformation of p38aApparently, the interaction of peptides induce a structure that
has features of stability that override the phosphate interactions
in p38a/T*GY*. Although numerous binding proteins and
enzymes have been observed to have two stable conformers,
relatively few, mainly large motor proteins or enzymes have
been demonstrated to have three (see, for example, Steitz,
2004 and Stock et al., 2000).EXPERIMENTAL PROCEDURES
Expression and Purification of p38a/T*GY* for Crystallography
To form p38a/T*GY*, DNA encoding mouse p38a derived from a pET14b
vector described previously (Wang et al., 1997) was subcloned into a derivative
of pETHisTEV lacking the TEV site and possessing the coding sequence for
constitutively active human MEK6/DD (MEk6/S207D/T211D) (Wilsbacher
and Cobb, 2001). The full coding sequence as cloned was MAHHHHHHAM-
mouse p38a. The tag assured the purification of the MAPK (p38a) away
from the MEK6/DD. The vector was transformed into BL21 (DE3 pLysS)
Escherichia coli cells. A starter culture containing 100 mg/ml ampicillin was
inoculated with a single colony and grown for 6 hr at 37C, then transferred
to 6 liters of terrific broth (Sigma) containing 100 mg/ml ampicillin, which was
grown to OD595 = 0.6. Protein expression was induced by adding 1 mM
IPTG and the culture was grown at 30C for an additional 6 hr. The cells
were harvested by centrifugation at 4000 rpm in a Sorvall GSA rotor for
30 min. The pellets were resuspended and flash frozen using liquid nitrogen
and stored at –80C. Cells were lysed in an Avestin cell disruptor, and the
lysate centrifuged at 35,000 rpm for 45 min. The supernatant was applied to
a Ni-NTA (QIAGEN) column and protein eluted with 250mM imidazole. The
protein was further purified by anion exchange column on MonoQ HR
5/5 column (GE Life Sciences), followed by phenyl Superose (HR5/5, GE Life
Sciences) and cation exchange (MonoS HR 5/5, GE Life Sciences). The flow1576 Structure 18, 1571–1578, December 8, 2010 ª2010 Elsevier Ltdthrough from the cation exchange column contained the phosphorylated
p38a/T*GY*. The protein was concentrated and the buffer changed to a final
buffer containing 50 mM HEPES (pH 7.5), 50 mM NaCl, 1 mM EDTA. The state
of phosphorylation was analyzed by electrospray mass spectrometry on a VG
30-250 quadrapole mass spectrometer equipped with the manufacturer’s
electrospray source. As can be seen from Figure S1, peaks corresponding
tomultiple phosphorylation states were observed, with a triply phosphorylated
species most abundant. A S28A mutant was identified that yields a homo-
geneous single species corresponding to p38a/T*GY* (why eliminating S28
reduced overall nonspecific phosphorylation is not known). This mutant was
also purified using the same protocol as for the wild-type. The mutation did
not affect the activity of p38a/T*GY*. A 1:3 molar ratio of p38a/T*GY* and
pepMEK3b was incubated overnight. The complex was then concentrated
to 10 mg/ml using Amicon concentrator.
Crystallography of p38a/T*GY*/pepMEK3b
The crystals were grown by the hanging drop method in 1.45 M (NH4)2SO4,
0.2M Li2SO4, 0.1MHEPES [pH 7.0–7.5], 16
C. The 0.33 0.043 0.04mmnee-
dles obtained were cryoprotected using 15% (v/v) glycerol in the crystallization
solution. The crystals were flash-frozen in liquid propane. High-resolution data
was collected at APS beam line 19BM at wavelength 1.05429 A˚ recorded
using charged-coupled device (CCD) detector SBC1. The data collection
and refinement parameters are given in Table S1. The data were indexed inte-
grated and scaled using HKL2000 (Otwinowski and Minor, 1997). The crystals
were isomorphous with those reported earlier for p38a with the same peptide
(Chang et al., 2002). The structure of p38a/pepMEK3b (SKGKSKRKKDLRIS
CASK) was directly used as a starting model. The model was refined with
iterative cycles of manual model building using Coot (Emsley and Cowtan,
2004) followed by refinement in CCP4 (1994). Coordinates were checked for
errors at the Protein Data Bank validation server, http://deposit.rcsb.org/
validate. Coordinates have been deposited in the Protein Data Bank (acces-
sion code 3P4K).
Purification of Uniformly 15N Labeled p38a and or p38a/T*GY*
Mouse p38a or p38a/T*GY* (same plasmid as used above) protein was ex-
pressed in Rosetta 2 cells (Novagen). One liter cultures of cells were grown
in M9 minimal medium supplemented with 1 g/liter 15NH4Cl (1 g/liter) and/or
3 g/liter 13C glucose at 37C to an A600 of 0.6–0.8 and then induced with
1mM IPTG. After induction for 16 hr at 20C, cells were centrifuged and
pellets resuspended in 50 mM Tris, 100 mM NaCl buffer (pH 8.0). Purification
protocols were the same detailed above. The yield for unphosphorylated p38a
was about 10 mg/liter cell culture, and for p38a/T*GY* about 1 mg/liter.
Nuclear Magnetic Resonance Analysis
All NMR spectra were recorded in buffer containing 50 mM HEPES (pH 7.5),
50 mM NaCl, and 1 mM EDTA. Peptide pepMEK3b was 5 mM where present.
Spectra were also recorded in the presence of 5 mMdithiothreitol, although no
significant chemical shift changes resulted of use of this reagent. Backbone
15N, and 1H chemical shift assignments of p38a and p38a/T*GY* with and
without docking site peptides derived from MEK3b were generated by
inspection and minor modification of prior assignments (BioMagResBank
entry 6468; Vogtherr et al., 2006) caused by differences in solution conditions.
15N/1H data TROSY spectra were obtained using data acquired at 25C using
a cryoprobe-equipped 800 MHz spectrometer. All spectra were processed
using NMRPipe and analyzed with NMRViewJ (Johnson, 2004). Phosphory-
lated p38a/T*GY* did not give a well-dispersed 15N-1H spectrum.ACCESSION NUMBERS
Coordinates have been deposited in the Protein Data Bank (accession code
3P4K).SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one table and can be
found with this article online at doi:10.1016/j.str.2010.09.015.All rights reserved
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